Differences in infectivity and induction of infertility: A comparative study of Chlamydia trachomatis strains in the murine model

Microbes and Infection

Volumn 15, Issue 3, 2013, Pages 219-229

  Carmichael, Jennifer R ^a   Tifrea, Delia ^a   Pal, Sukumar ^a   De la Maza, Luis M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chlamydia; Infertility; Murine; Pathogenicity

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL SHEDDING; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; COMPARATIVE STUDY; CONTROLLED STUDY; ECTOPIC PREGNANCY; EXPERIMENTAL MODEL; FEMALE; FEMALE FERTILITY; FEMALE INFERTILITY; GENE MUTATION; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PATHOGENESIS; PELVIC INFLAMMATORY DISEASE; PRIORITY JOURNAL; SEROTYPE;

ANIMALS; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE; FERTILITY; INFERTILITY; MALE; MEDROXYPROGESTERONE ACETATE; MICE; MICE, INBRED C3H; STATISTICS, NONPARAMETRIC; VAGINA;

CHLAMYDIA; CHLAMYDIA TRACHOMATIS; MURINAE; MUS;

EID: 84874960573     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.12.001     Document Type: Article

References (48)

1. Westrom L., Joesoef R., Reynolds G., Hagdu A., Thompson S.E. Pelvic inflammatory disease and fertility. A cohort study of 1844 women with laparoscopically verified disease and 657 control women with normal laparoscopic results. Sex. Transm. Dis. 1992, 19:185-192.
2. Ness R.B., Smith K.J., Chang C.C., Schisterman E.F., Bass D.C. Prediction of pelvic inflammatory disease among young, single, sexually active women. Sex. Transm. Dis. 2006, 33:137-142.
3. Miller W.C., Ford C.A., Morris M., Handcock M.S., Schmitz J.L., Hobbs M.M., Cohen M.S., Harris K.M., Udry J.R. Prevalence of chlamydial and gonococcal infections among young adults in the United States. J. Am. Med. Assoc. 2004, 291:2229-2236.
4. Chlamydia screening among sexually active young female enrollees of health plans-United States, 2000-2007. Morb. Mortal. Wkly. Rep. 2009, 58:362-365.
5. Low N., Egger M., Sterne J.A., Harbord R.M., Ibrahim F., Lindblom B., Herrmann B. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex. Transm. Infect. 2006, 82:212-218.
6. Land J.A., Van Bergen J.E., Morre S.A., Postma M.J. Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. Hum. Reprod. Update 2009, 16:189-204.
7. Wang S.P., Grayston J.T. Classification of trachoma virus strains by protection of mice from toxic death. J. Immunol. 1963, 90:849-856.
8. Wang S.P., Grayston J. Microimmunofluorescence serology of Chlamydia trachomatis. Medical Virology 1984, III. Elsevier Science Pub., New York.
9. Stephens R.S., Sanchez-Pescador R., Wagar E.A., Inouye C., Urdea M.S. Diversity of Chlamydia trachomatis major outer membrane protein genes. J. Bacteriol. 1987, 169:3879-3885.
10. Fitch W.M., Peterson E.M., de la Maza L.M. Phylogenetic analysis of the outer-membrane-protein genes of Chlamydiae, and its implication for vaccine development. Mol. Biol. E 1993, 10:892-913.
11. Geisler W.M., Suchland R.J., Whittington W.L., Stamm W.E. The relationship of serovar to clinical manifestations of urogenital Chlamydia trachomatis infection. Sex. Transm. Dis. 2003, 30:160-165.
12. Dean D., Oudens E., Bolan G., Padian N., Schachter J. Major outer membrane protein variants of Chlamydia trachomatis are associated with severe upper genital tract infections and histopathology in San Francisco. J. Infect. Dis. 1995, 172:1013-1022.
13. Morre S.A., Rozendaal L., Van Valkengoed I.G., Boeke A.J., Van Voorst Vader P.C., Schirm J., De Blok S., Van Den Hoek J.A., Van Doornum G.J., Meijer C.J., Van Den Brule A.J. Urogenital Chlamydia trachomatis serovars in men and women with a symptomatic or asymptomatic infection: an association with clinical manifestations?. J. Clin. Microbiol. 2000, 38:2292-2296.
14. Suchland R.J., Eckert L.O., Hawes S.E., Stamm W.E. Longitudinal assessment of infecting serovars of Chlamydia trachomatis in Seattle public health clinics: 1988-1996. Sex. Transm. Dis. 2003, 30:357-361.
15. Lan J., Melgers I., Meijer C.J., Walboomers J.M., Roosendaal R., Burger C., Bleker O.P., Van Den Brule A.J. Prevalence and serovar distribution of asymptomatic cervical Chlamydia trachomatis infections as determined by highly sensitive PCR. J. Clin. Microbiol. 1995, 33:3194-3197.
16. Millman K., Black C.M., Stamm W.E., Jones R.B., Hook E.W., Martin D.H., Bolan G., Tavare S., Dean D. Population-based genetic epidemiologic analysis of Chlamydia trachomatis serotypes and lack of association between ompA polymorphisms and clinical phenotypes. Microbe. Infect. 2006, 8:604-611.
17. Tuffrey M., Alexander F., Woods C., Taylor-Robinson D. Genetic susceptibility to chlamydial salpingitis and subsequent infertility in mice. J. Reprod. Fertil. 1992, 95:31-38.
18. Tuffrey M., Taylor-Robinson D. Progesterone as a key factor in the development of a mouse model for genital-tract infection with Chlamydia trachomatis. FEMS Microbiol. Lett. 1981, 12:111-115.
19. Ito J.I., Lyons J.M., Airo-Brown L.P. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection. Infect. Immun. 1990, 58:2021-2023.
20. Lyons J.M., Morre S.A., Airo-Brown L.P., Pena A.S., Ito J.I. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice. BMC Infect. Dis. 2005, 5:105.
21. Sturdevant G.L., Kari L., Gardner D.J., Olivares-Zavaleta N., Randall L.B., Whitmire W.M., Carlson J.H., Goheen M.M., Selleck E.M., Martens C., Caldwell H.D. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract. Infect. Immun. 2010, 78:3660-3668.
22. Tuffrey M., Falder P., Gale J., Taylor-Robinson D. Salpingitis in mice induced by human strains of Chlamydia trachomatis. Br. J. Exp. Pathol. 1986, 67:605-616.
23. Pal S., Sarcon A.K., de la Maza L.M. C3H male mice with severe combined immunodeficiency cannot clear a urethral infection with a human serovar of Chlamydia trachomatis. Infect. Immun. 2009, 77:5602-5607.
24. Caldwell H.D., Kromhout J., Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 1981, 31:1161-1176.
25. Furr P.M., Taylor-Robinson D. Factors influencing the ability of different mycoplasmas to colonize the genital tract of hormone-treated female mice. Int. J. Exp. Pathol. 1993, 74:97-101.
26. Pal S., Fielder T.J., Peterson E.M., de la Maza L.M. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis. Infect. Immun. 1994, 62:3354-3362.
27. Ossewaarde J.M., De Vries A., Bestebroer T., Angulo A.F. Application of a Mycoplasma group-specific PCR for monitoring decontamination of Mycoplasma-infected Chlamydia sp. strains. Appl. Environ. Microbiol. 1996, 62:328-331.
28. Pal S., Peterson E.M., de la Maza L.M. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect. Immun. 2005, 73:8153-8160.
29. Lyons J.M., Morre S.A., Airo-Brown L.P., Pena A.S., Ito J.I. Comparison of multiple genital tract infections with Chlamydia trachomatis in different strains of female mice. J. Microbiol. Immunol. Infect. 2005, 38:383-393.
30. Ramsey K.H., Dewolfe J.L., Salyer R.D. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis. Infect. Immun. 2000, 68:7186-7189.
31. Tuffrey M., Falder P., Gale J., Quinn R., Taylor-Robinson D. Infertility in mice infected genitally with a human strain of Chlamydia trachomatis. J. Reprod. Fertil. 1986, 78:251-260.
32. Darville T., Andrews C.W., Laffoon K.K., Shymasani W., Kishen L.R., Rank R.G. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect. Immun. 1997, 65:3065-3073.
33. Miyairi I., Mahdi O.S., Ouellette S.P., Belland R.J., Byrne G.I. Different growth rates of Chlamydia trachomatis biovars reflect pathotype. J. Infect. Dis. 2006, 194:350-357.
34. Carlson J.H., Hughes S., Hogan D., Cieplak G., Sturdevant D.E., Mcclarty G., Caldwell H.D., Belland R.J. Polymorphisms in the Chlamydia trachomatis cytotoxin locus associated with ocular and genital isolates. Infect. Immun. 2004, 72:7063-7072.
35. Hill J.A., Barbieri R.L., Anderson D.J. Immunosuppressive effects of danazol in vitro. Fertil. Steril 1987, 48:414-418.
36. Pal S., Hui W., Peterson E.M., de la Maza L.M. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection. J. Med. Microbiol. 1998, 47:599-605.
37. Binet R., Maurelli A.T. Transformation and isolation of allelic exchange mutants of Chlamydia psittaci using recombinant DNA introduced by electroporation. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:292-297.
38. Wang Y., Kahane S., Cutcliffe L.T., Skilton R.J., Lambden P.R., Clarke I.N. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog. 2011, 7:e1002258.
39. Jeffrey B.M., Suchland R.J., Quinn K.L., Davidson J.R., Stamm W.E., Rockey D.D. Genome sequencing of recent clinical Chlamydia trachomatis strains identifies loci associated with tissue tropism and regions of apparent recombination. Infect. Immun. 2010, 78:2544-2553.
40. Kari L., Whitmire W.M., Carlson J.H., Crane D.D., Reveneau N., Nelson D.E., Mabey D.C., Bailey R.L., Holland M.J., Mcclarty G., Caldwell H.D. Pathogenic diversity among Chlamydia trachomatis ocular strains in nonhuman primates is affected by subtle genomic variations. J. Infect. Dis. 2008, 197:449-456.
41. Ramsey K.H., Sigar I.M., Schripsema J.H., Denman C.J., Bowlin A.K., Myers G.A., Rank R.G. Strain and virulence diversity in the mouse pathogen Chlamydia muridarum. Infect. Immun. 2009, 77:3284-3293.
42. Geisler W.M., Suchland R.J., Rockey D.D., Stamm W.E. Epidemiology and clinical manifestations of unique Chlamydia trachomatis isolates that occupy nonfusogenic inclusions. J. Infect. Dis. 2001, 184:879-884.
43. Xia M., Suchland R.J., Bumgarner R.E., Peng T., Rockey D.D., Stamm W.E. Chlamydia trachomatis variant with nonfusing inclusions: growth dynamic and host-cell transcriptional response. J. Infect. Dis. 2005, 192:1229-1236.
44. Rank R.G., Bowlin A.K., Tormanen K.I., Wang Y., Maurelli A.T. Effect of inflammatory response on in vivo competition between two chlamydial variants in the guinea pig model of inclusion conjunctivitis. Infect. Immun. 2011, 80:612-619.
45. Stephens R.S. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol. 2003, 11:44-51.
46. Campbell L.A., Patton D.L., Moore D.E., Cappuccio A.L., Mueller B.A., Wang S.P. Detection of Chlamydia trachomatis deoxyribonucleic acid in women with tubal infertility. Fertil. Steril. 1993, 59:45-50.
47. Orlando P.A., Gatenby R.A., Giuliano A.R., Brown J.S. Evolutionary ecology of Human Papillomavirus: trade-offs, coexistence, and origins of high-risk and low-risk types. J. Infect. Dis. 2012, 205:272-279.
48. de la Maza L.M., Pal S., Khamesipour A., Peterson E.M. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect. Immun. 1994, 62:2094-2097.